The US Food and Drug Administration (FDA) has approved the messenger RNA-based (mRNA) vaccine against respiratory syncytial virus (RSV) for people ages 60 and older. The vaccine, made by ...
The US Food and Drug Administration (FDA) approved mRESVIA (mRNA-1345, Moderna), a vaccine for respiratory syncytial virus (RSV). The mRNA vaccine is approved for adults aged 60 years or ...
The U.S. Food and Drug Administration on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi to include the treatment of adults with a type of blood cancer that ...
This article discusses Donald Trump convicted on 34 charges of falsifying business records, the upcoming PCE data, Boeing's ...
US President Joe Biden said Israel had offered a new proposal in negotiations with Hamas to free hostages and bring about a lasting ceasefire, as he urged both sides in the conflict to embrace his ...
Reports of a rare nervous system disorder are "more common than expected" in older U.S. adults who got the new RSV vaccines.